The extensive survey and analysis of ALS-related SOD1 mutations and the patients’ natural histories provide data that could serve in the design and interpretation of future clinical trials targeted at patients with SOD1 mutations. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.